Business Description
Solara Active Pharma Sciences Ltd
ISIN : INE624Z01016
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 1.08 | |||||
Debt-to-EBITDA | -3.61 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.48 | |||||
Beneish M-Score | -4.17 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8 | |||||
3-Year Book Growth Rate | -16.2 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 10.71 | |||||
9-Day RSI | 25.58 | |||||
14-Day RSI | 36.11 | |||||
6-1 Month Momentum % | 57.74 | |||||
12-1 Month Momentum % | 50.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.64 | |||||
Quick Ratio | 0.35 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 222.87 | |||||
Days Sales Outstanding | 133.48 | |||||
Days Payable | 145.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.32 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 37.54 | |||||
Operating Margin % | -5.14 | |||||
Net Margin % | -44.02 | |||||
FCF Margin % | 5.26 | |||||
ROE % | -43.63 | |||||
ROA % | -20.96 | |||||
ROIC % | -3.05 | |||||
ROC (Joel Greenblatt) % | -21.29 | |||||
ROCE % | -24.91 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.27 | |||||
PB Ratio | 1.74 | |||||
Price-to-Tangible-Book | 3.08 | |||||
Price-to-Free-Cash-Flow | 24.05 | |||||
Price-to-Operating-Cash-Flow | 14.98 | |||||
EV-to-EBIT | -6.85 | |||||
EV-to-EBITDA | -9.38 | |||||
EV-to-Revenue | 2.04 | |||||
EV-to-FCF | 38.74 | |||||
Price-to-Projected-FCF | 4.14 | |||||
Earnings Yield (Greenblatt) % | -14.6 | |||||
FCF Yield % | 4.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Solara Active Pharma Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 12,889.2 | ||
EPS (TTM) (₹) | -145.269 | ||
Beta | 1.83 | ||
Volatility % | 57.79 | ||
14-Day RSI | 36.11 | ||
14-Day ATR (₹) | 23.661152 | ||
20-Day SMA (₹) | 471.837813 | ||
12-1 Month Momentum % | 50.9 | ||
52-Week Range (₹) | 264.510801 - 559.389655 | ||
Shares Outstanding (Mil) | 39.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Solara Active Pharma Sciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Solara Active Pharma Sciences Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Solara Active Pharma Sciences Ltd Frequently Asked Questions
What is Solara Active Pharma Sciences Ltd(BOM:541540)'s stock price today?
When is next earnings date of Solara Active Pharma Sciences Ltd(BOM:541540)?
Does Solara Active Pharma Sciences Ltd(BOM:541540) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |